"equitable"

#13362490

23 February 2026

A demonstrator gathers signatures opposing the migration pact. Polish opposition groups protest outside the Presidential Palace in Warsaw, Poland, on February 21, 2026, urging President Karol Nawrocki to veto the SAFE Bill, which enables Poland to access EUR 43.7 billion in EU loans for defense projects. The bill, approved by the Senate but opposed by Law and Justice and Confederation lawmakers, sparks debates over its political implications and potential misuse, with Prime Minister Donald Tusk advocating for its swift enactment.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#13362498

23 February 2026

A demonstrator gathers signatures opposing the migration pact. Polish opposition groups protest outside the Presidential Palace in Warsaw, Poland, on February 21, 2026, urging President Karol Nawrocki to veto the SAFE Bill, which enables Poland to access EUR 43.7 billion in EU loans for defense projects. The bill, approved by the Senate but opposed by Law and Justice and Confederation lawmakers, sparks debates over its political implications and potential misuse, with Prime Minister Donald Tusk advocating for its swift enactment.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#13362499

23 February 2026

A demonstrator gathers signatures opposing the migration pact. Polish opposition groups protest outside the Presidential Palace in Warsaw, Poland, on February 21, 2026, urging President Karol Nawrocki to veto the SAFE Bill, which enables Poland to access EUR 43.7 billion in EU loans for defense projects. The bill, approved by the Senate but opposed by Law and Justice and Confederation lawmakers, sparks debates over its political implications and potential misuse, with Prime Minister Donald Tusk advocating for its swift enactment.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#13295607

9 February 2026

The AbbVie logo appears on a laptop computer screen in this photo illustration in Athens, Greece, on February 9, 2026. Vaccine manufacturers play a central role in global public health, investing in research, development, and distribution of new immunization products. As health challenges evolve worldwide, the industry faces growing demands for innovation, supply chain resilience, and equitable access to vaccines. (Photo Illustration by Nikolas Kokovlis/NurPhoto)

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#13295608

9 February 2026

The Amgen logo appears on a laptop computer screen in this photo illustration in Athens, Greece, on February 9, 2026. Vaccine manufacturers play a central role in global public health, investing in research, development, and distribution of new immunization products. As health challenges evolve worldwide, the industry faces growing demands for innovation, supply chain resilience, and equitable access to vaccines. (Photo Illustration by Nikolas Kokovlis/NurPhoto)

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#13295609

9 February 2026

The AstraZeneca logo appears on a laptop computer screen in this photo illustration in Athens, Greece, on February 9, 2026. Vaccine manufacturers play a central role in global public health, investing in research, development, and distribution of new immunization products. As health challenges evolve worldwide, the industry faces growing demands for innovation, supply chain resilience, and equitable access to vaccines. (Photo Illustration by Nikolas Kokovlis/NurPhoto)

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#13295610

9 February 2026

The Bavarian Nordic logo appears on a laptop computer screen in this photo illustration in Athens, Greece, on February 9, 2026. Vaccine manufacturers play a central role in global public health, investing in research, development, and distribution of new immunization products. As health challenges evolve worldwide, the industry faces growing demands for innovation, supply chain resilience, and equitable access to vaccines. (Photo Illustration by Nikolas Kokovlis/NurPhoto)

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#13295611

9 February 2026

The BioNTech logo appears on a laptop computer screen in Athens, Greece, on February 9, 2026. Vaccine manufacturers continue to play a central role in global public health, investing in research, development, and distribution of new immunization products. As health challenges evolve worldwide, the industry faces growing demands for innovation, supply chain resilience, and equitable access to vaccines. (Photo Illustration by Nikolas Kokovlis/NurPhoto)

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#13295612

9 February 2026

The Bristol Myers Squibb logo appears on a laptop computer screen in this photo illustration in Athens, Greece, on February 9, 2026. Vaccine manufacturers play a central role in global public health, investing in research, development, and distribution of new immunization products. As health challenges evolve worldwide, the industry faces growing demands for innovation, supply chain resilience, and equitable access to vaccines. (Photo Illustration by Nikolas Kokovlis/NurPhoto)

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#13295613

9 February 2026

The CSL logo appears on a laptop computer screen in this photo illustration in Athens, Greece, on February 9, 2026. Vaccine manufacturers continue to play a central role in global public health, investing in research, development, and distribution of new immunization products. As health challenges evolve worldwide, the industry faces growing demands for innovation, supply chain resilience, and equitable access to vaccines. (Photo Illustration by Nikolas Kokovlis/NurPhoto)

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#13295614

9 February 2026

The Dynavax logo appears on a laptop computer screen in this photo illustration in Athens, Greece, on February 9, 2026. Vaccine manufacturers play a central role in global public health, investing in research, development, and distribution of new immunization products. As health challenges evolve worldwide, the industry faces growing demands for innovation, supply chain resilience, and equitable access to vaccines. (Photo Illustration by Nikolas Kokovlis/NurPhoto)

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#13295615

9 February 2026

The Eli Lilly logo appears on a laptop computer screen in this photo illustration in Athens, Greece, on February 9, 2026. Vaccine manufacturers play a central role in global public health, investing in research, development, and distribution of new immunization products. As health challenges evolve worldwide, the industry faces growing demands for innovation, supply chain resilience, and equitable access to vaccines. (Photo Illustration by Nikolas Kokovlis/NurPhoto)

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#13295616

9 February 2026

The Emergent logo appears on a laptop computer screen in this photo illustration in Athens, Greece, on February 9, 2026. Vaccine manufacturers play a central role in global public health, investing in research, development, and distribution of new immunization products. As health challenges evolve worldwide, the industry faces growing demands for innovation, supply chain resilience, and equitable access to vaccines. (Photo Illustration by Nikolas Kokovlis/NurPhoto)

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#13295617

9 February 2026

The Novavax logo appears on a laptop computer screen in this photo illustration in Athens, Greece, on February 9, 2026. Vaccine manufacturers continue to play a central role in global public health, investing in research, development, and distribution of new immunization products. As health challenges evolve worldwide, the industry faces growing demands for innovation, supply chain resilience, and equitable access to vaccines. (Photo Illustration by Nikolas Kokovlis/NurPhoto)

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#13295618

9 February 2026

The Gilead logo appears on a laptop computer screen in this photo illustration in Athens, Greece, on February 9, 2026. Vaccine manufacturers play a central role in global public health, investing in research, development, and distribution of new immunization products. As health challenges evolve worldwide, the industry faces growing demands for innovation, supply chain resilience, and equitable access to vaccines. (Photo Illustration by Nikolas Kokovlis/NurPhoto)

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#13295619

9 February 2026

The GSK logo appears on a laptop computer screen in this photo illustration in Athens, Greece, on February 9, 2026. Vaccine manufacturers play a central role in global public health, investing in research, development, and distribution of new immunization products. As health challenges evolve worldwide, the industry faces growing demands for innovation, supply chain resilience, and equitable access to vaccines. (Photo Illustration by Nikolas Kokovlis/NurPhoto)

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.